Novartis Investigative Site

OYS FIN-90029

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Cardiovascular Disease, Neoplasms, Breast, Type 2 Diabetes Mellitus

Studies at this site

• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early